Subclinical inflammation and insulin resistance in non-insulin-dependent diabetes mellitus;Inflammation chronique subclinique et insulinorésistance chez les diabétiques non insulinodépendants

Immuno-Analyse et Biologie Specialisee

Volumn 23, Issue 6, 2008, Pages 353-357

  Aouni, Z ^a   Oudi, M ^a   Ourtani, H ^a   Mazigh, C ^a   Essaies, O ^a   Nsiri, B ^a   Zidi, B ^a   Machghoul, S ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

Chronic inflammation; High sensitivity C reactive protein; Insulin resistance; Non insulin dependent diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; INSULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 57249094302     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2008.07.012     Document Type: Article

References (14)

1. Tiejiani W., Joan P.D., Richard P.D., Christopher T.S., and Maurizio T. Association of C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin. Am J Epidemiol 155 (2002) 65-71
2. katherine E., Francesco N., Raffaele M., Giovani G., Francesco G., Myriam C., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Circulation 106 (2002) 2067
3. Kassab A., Laradi S., Ferchichi S., Omezzine A., Charfeddine B., Ammar H., et al. Paramètres du stress oxydant dans le diabète de type 2. Immuno Analyse Biologie Specialisee 18 (2003) 79-85
4. Dana E.K., Arch J.M., Thomas A.B., and Williams S.P. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26 (2003) 1535-1539
5. Noriyuki N., Tsunehito S., and Mriko W. Association between fasting glucose and C-reactive protein in jepanese population: the Minoh study. Diabetes Res Clin Pract 69 (2005) 88-98
6. Carl G.G., and Carl D.A. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. Eur Heart J 23 (2004) 2120-2124
7. Festa A., D'Agostino R., Tracy R.P., and Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type2 diabetes. Diabetes 51 (2002) 1131-1137
8. Frank B.H., James B.M., Tricia Y.L., Nader R., and JoAnn E.M. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53 (2004) 693-700
9. Festa A., D'Agostino R., Haward G., Mykkanen L., Tracy R.P., and Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 102 (2000) 42
10. Robert Y.L.Z., Soren G., Abraham T., Annaswammy R., Brian R., Paul M.N., et al. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis 197 (2008) 931-936
11. Futoshi A., Naohiko T., Mikiko N., Tatsuhiko O., Tetsunori S., and Hironobu Y. High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism 54 (2005) 552-558
12. Ataru T., Shoichiro N., Mitsuo F., Masahiko S., Takahide O., Satoru Y., et al. C-reactive protein and insulin resistance in non obese Japanese type 2 diabetic patients. Metabolism 51 (2002) 1578-1581
13. Aruna D.P., JoAnn E.M., Nader R., Julie E.B., and Paul M.R. C-reactive protein, Interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
14. Eun S.K., Hyeong J.K., Chul W.A., Cheol W.P., Bong S.C., Sung K.L., et al. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and micro vascular complications in type 2 diabetes. Diabetes Res Clin Pract 69 (2005) 151-159